Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study.

[1]  A. Bjørnebekk,et al.  Anabolic-androgenic steroid use among women - A qualitative study on experiences of masculinizing, gonadal and sexual effects. , 2020, The International journal on drug policy.

[2]  E. B. Rognli,et al.  Factors associated with drug use in prison – results from the Norwegian offender mental health and addiction (NorMA) study , 2020, Health & justice.

[3]  G. Kanayama,et al.  Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians , 2020, Psychotherapy and Psychosomatics.

[4]  L. Westlye,et al.  Anabolic androgenic steroid dependence is associated with executive dysfunction. , 2020, Drug and alcohol dependence.

[5]  J. McVeigh,et al.  The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment , 2020, Substance abuse : research and treatment.

[6]  K. Dalhoff,et al.  Anabolic-androgenic steroids and the risk of imprisonment. , 2019, Drug and alcohol dependence.

[7]  M. L. Jørstad,et al.  Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires , 2019, Substance Abuse Treatment, Prevention, and Policy.

[8]  L. Westlye,et al.  Structural brain characteristics of anabolic–androgenic steroid dependence in men , 2019, Addiction.

[9]  L. Westlye,et al.  Cognitive Performance and Structural Brain Correlates in Long-Term Anabolic-Androgenic Steroid Exposed and Nonexposed Weightlifters , 2019, Neuropsychology.

[10]  M. Kaufman,et al.  Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia? , 2019, Neuroscience & Biobehavioral Reviews.

[11]  E. Arnevik,et al.  Anabolic androgenic steroid dependence is associated with impaired emotion recognition , 2019, Psychopharmacology.

[12]  Kent Hutchison,et al.  Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. , 2019, The American journal of psychiatry.

[13]  H. Horwitz,et al.  Health consequences of androgenic anabolic steroid use , 2018, Journal of internal medicine.

[14]  E. B. Rognli,et al.  Inmates with Harmful Substance Use Increase Both Exercise and Nicotine Use Under Incarceration , 2018, International journal of environmental research and public health.

[15]  B. Larance,et al.  Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users , 2018, Drug and alcohol review.

[16]  J. McVeigh,et al.  Identifying a typology of men who use anabolic androgenic steroids (AAS). , 2018, The International journal on drug policy.

[17]  P. Hovind,et al.  Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma? , 2018, Journal of hypertension.

[18]  P. Due-Tønnessen,et al.  Structural Brain Imaging of Long-Term Anabolic-Androgenic Steroid Users and Nonusing Weightlifters , 2017, Biological Psychiatry.

[19]  S. Fazel,et al.  Substance use disorders in prisoners: an updated systematic review and meta‐regression analysis in recently incarcerated men and women , 2017, Addiction.

[20]  Michael T. Lu,et al.  Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use , 2017, Circulation.

[21]  A. Christiansen,et al.  Outline of a typology of men’s use of anabolic androgenic steroids in fitness and strength training environments* , 2017 .

[22]  R. Coomber,et al.  The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use. , 2017, The International journal on drug policy.

[23]  P. Fischbach.  The role of illicit drug use in sudden death in the young , 2017, Cardiology in the Young.

[24]  S. Fazel,et al.  Mental health of prisoners: prevalence, adverse outcomes, and interventions. , 2016, The lancet. Psychiatry.

[25]  A. Juul,et al.  Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study , 2016, PloS one.

[26]  J. Mond,et al.  Anabolic steroid use and body image psychopathology in men: Delineating between appearance- versus performance-driven motivations. , 2016, Drug and alcohol dependence.

[27]  L. Ekström,et al.  Recruitment to doping and help-seeking behavior of eight female AAS users , 2016, Substance Abuse Treatment, Prevention, and Policy.

[28]  E. Nieschlag,et al.  MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. , 2015, European journal of endocrinology.

[29]  L. Holmberg,et al.  Anabolic steroids and cardiovascular risk: A national population-based cohort study. , 2015, Drug and alcohol dependence.

[30]  S. Bhasin,et al.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. , 2015, Addiction.

[31]  T. Clausen,et al.  The Norwegian Offender Mental Health and Addiction Study – Design and Implementation of a National Survey and Prospective Cohort Study , 2015, Substance abuse : research and treatment.

[32]  P. Girardi,et al.  Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review , 2015, Current neuropharmacology.

[33]  C. S. Andreassen,et al.  Anabolic-Androgenic Steroid use in the Nordic Countries: A Meta-Analysis and Meta-Regression Analysis , 2014 .

[34]  B. Morentin,et al.  Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15-49-year-old subjects: a forensic case-control study. , 2014, Addiction.

[35]  R. Wood,et al.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. , 2014, Endocrine reviews.

[36]  C. S. Andreassen,et al.  The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. , 2014, Annals of epidemiology.

[37]  Edward D. Kim,et al.  Anabolic steroid-induced hypogonadism: diagnosis and treatment. , 2014, Fertility and sterility.

[38]  L. Lipshultz,et al.  Anabolic steroid induced hypogonadism in young men. , 2013, The Journal of urology.

[39]  J. Parry,et al.  Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study , 2013, BMJ Open.

[40]  H. Nøkleby.  Use of doping agents and symptoms of eating disorders among male and female patients in drug addiction treatment , 2013 .

[41]  F. Skårderud,et al.  Body Practices Among Male Drug Abusers. Meanings of Workout and use of Doping Agents in a Drug Treatment Setting , 2013, International Journal of Mental Health and Addiction.

[42]  J. Ahlner,et al.  Anabolic androgenic steroids in police cases in Sweden 1999-2009. , 2012, Forensic science international.

[43]  M. Berglund,et al.  Anabolic Androgenic Steroids in the General Population: User Characteristics and Associations with Substance Use , 2012, European Addiction Research.

[44]  M. Barnett,et al.  The Anabolic 500 Survey: Characteristics of Male Users versus Nonusers of Anabolic‐Androgenic Steroids for Strength Training , 2011, Pharmacotherapy.

[45]  Tonya Dodge,et al.  The use of anabolic androgenic steroids and polypharmacy: a review of the literature. , 2011, Drug and alcohol dependence.

[46]  I. Thiblin,et al.  Use of anabolic androgenic steroids in substance abusers arrested for crime. , 2010, Drug and alcohol dependence.

[47]  A. Rane,et al.  Dual use of anabolic-androgenic steroids and narcotics in Sweden. , 2010, Drug and alcohol dependence.

[48]  R. Wood,et al.  Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. , 2010, Drug and alcohol dependence.

[49]  I. Thiblin,et al.  The significance of anabolic androgenic steroids in a Swedish prison population. , 2010, Comprehensive psychiatry.

[50]  R. Wood,et al.  Anabolic-androgenic steroid dependence: an emerging disorder. , 2009, Addiction.

[51]  Arthur N Westover,et al.  Acute myocardial infarction in young adults who abuse amphetamines. , 2008, Drug and alcohol dependence.

[52]  R. Kristoffersen,et al.  Correctional Statistics of Denmark, Finland, Iceland, Norway and Sweden 2004 - 2008 , 2007 .

[53]  H. Druid,et al.  Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids. , 2006, Drug and alcohol dependence.

[54]  Anna Petersson,et al.  Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study. , 2006, Drug and alcohol dependence.

[55]  R. C. Hall,et al.  Psychiatric complications of anabolic steroid abuse. , 2005, Psychosomatics.

[56]  A. H. Berman,et al.  Evaluation of the Drug Use Disorders Identification Test (DUDIT) in Criminal Justice and Detoxification Settings and in a Swedish Population Sample , 2004, European Addiction Research.

[57]  R. Weiss,et al.  Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? , 2003, The Journal of clinical psychiatry.

[58]  R. Dawson,et al.  Drugs in sport - the role of the physician. , 2001, The Journal of endocrinology.

[59]  T. Seppälä,et al.  Drug abuse of Finnish male prisoners in 1995. , 1998, Forensic science international.

[60]  E. Kouri,et al.  Anabolic-androgenic steroid use among 133 prisoners. , 1996, Comprehensive psychiatry.

[61]  E. Hill,et al.  Symptoms and correlates of anabolic-androgenic steroid dependence. , 1991, British journal of addiction.

[62]  T. Beresford,et al.  Anabolic androgenic steroids and suicide. , 1989, The American journal of psychiatry.

[63]  T. Rosén,et al.  Patients who Seek Treatment for AAS Abuse in Sweden : Description of Characteristics , Substance Pattern and Mortality Rate , 2019 .

[64]  P. Lichtenstein,et al.  Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men. , 2014, Addiction.

[65]  A. Sonmez,et al.  Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. , 2012, Endocrine journal.

[66]  S. Fazel,et al.  The health of prisoners , 2011, The Lancet.

[67]  J. Keene.  Drug Use Among Prisoners Before, During and After Custody , 1997 .